BGI Genomics Co., Ltd. - PE Ratio

The PE Ratio as of September 2026 (TTM) for BGI Genomics Co., Ltd. (300676.SZ) is -26.43

According to BGI Genomics Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -26.43. This represents a change of -81.42% compared to the average of -142.22 of the last 4 quarters.

BGI Genomics Co., Ltd. (300676.SZ) Historical PE Ratio (quarterly & annually)

How has 300676.SZ PE Ratio performed in the past?

The mean historical PE Ratio of BGI Genomics Co., Ltd. over the last ten years is 60.92. The current -26.43 PE Ratio has changed -4438.40% with respect to the historical average. Over the past ten years (40 quarters), 300676.SZ's PE Ratio was at its highest in in the December 2019 quarter at 1.10K. The PE Ratio was at its lowest in in the March 2026 quarter at -435.04.

BGI Genomics Co., Ltd. (300676.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BGI Genomics Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BGI Genomics Co., Ltd. (300676.SZ) Average PE Ratio

How has 300676.SZ PE Ratio performed in the past?

The current PE Ratio of BGI Genomics Co., Ltd. (300676.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BGI Genomics Co., Ltd. (300676.SZ) PE Ratio vs. Peers

How is 300676.SZ’s PE Ratio compared to its peers?

BGI Genomics Co., Ltd.’s PE Ratio is less than Autobio Diagnostics Co., Ltd. (18.29), less than Guangzhou Kingmed Diagnostics Group Co., Ltd. (122.02), greater than Winning Health Technology Group Co., Ltd. (-33.71), less than DaShenLin Pharmaceutical Group Co., Ltd. (15.20), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (10.20), less than Double Medical Technology Inc. (22.46), less than Shenyang Xingqi Pharmaceutical Co.,Ltd (12.28), less than Topchoice Medical Corporation (22.58), less than Mabwell (Shanghai) Bioscience Co., Ltd. (-10.96), less than iRay Technology Company Limited (28.13),

Build a custom stock screener for BGI Genomics Co., Ltd. (300676.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BGI Genomics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BGI Genomics Co., Ltd. (300676.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BGI Genomics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.